CDK9 inhibitors for haematological malignancy treatment
Drug Target Review,
A novel category of drugs, CDK9 inhibitors, emerges as potent agents capable of suppressing the transcription of these anti-apopt…
A novel category of drugs, CDK9 inhibitors, emerges as potent agents capable of suppressing the transcription of these anti-apopt…
These new findings evidence the necessity of more research in Gln metabolism to define the best therapeutic strategies for…
A promising new treatment for hematological malignancies August 11, 2023 Source:drugdu 21 A new research perspective was…
A new research perspective was published inOncotarget'sVolume 14on August 7, 2023, entitled, CDK9 INHIBITORS: a promising…
Eine neue Forschungsperspektive mit dem Titel „CDK9-INHIBITOREN: ein vielversprechender Kombinationspartner bei der Behandlung hä…
“[…] CDK9 inhibitors could play a role in future treatments of hematological diseases and could be a great ally when combined…
A new research perspective titled "CDK9 INHIBITORS: a promising combination partner in the treatment of hematological…
“[…] CDK9 inhibitors could play a role in future treatments of hematological diseases and could be a great ally when combined…
A new research perspective was published in Oncotarget's Volume 14 on August 7, 2023, entitled, "CDK9 INHIBITORS: a promising…
A new research perspective was published in Oncotarget's Volume 14 on August 7, 2023, entitled, "CDK9 INHIBITORS: a promising…
image: Figure 1: PET scan at screening (A), 5 months (B) and 8 months on treatment (C).
"[...] CDK9 inhibitors could play a role in future treatments of hematological diseases and could be a great ally when combined…
[...] CDK9 inhibitors could play a role in future treatments of hematological diseases and could be a great ally when combined…